Prescient Therapeutics Investor Briefing – 19 October
Prescient Therapeutics (ASX: PTX) Webcast Replay
Prescient Therapeutics (ASX: PTX) CEO Steven Yatomi-Clarke and Director of Scientific Affairs, Rebecca Lim, present a special ‘OmniCAR Explainer’ session. They provide an overview into the amazing field of CAR-T and step through the new preclinical data, which demonstrates key OmniCAR features in next gen CAR-Ts.
Recorded on 19 October 2021 at 11am (AEDT).